AKT1 and neoplasm: Administration of PI3K inhibitor wortmannin, AKT inhibitor triciribine, and mTORC1 inhibitors rapamycin [18] and metformin [87], significantly reduces TI-Tregs number and function, resulting in tumor reduction.